Optimization of methods to assess human mucosal T-cell responses to HIV infection.

The majority of HIV-1 infections occur via sexual transmission at mucosal epithelia lining the vagina, cervix or rectum. Mucosal tissues also serve as viral reservoirs. However, our knowledge of human mucosal T-cell responses is limited. There is a need for reliable, sensitive, and reproducible methods for assessing mucosal immunity. Here we report on the collaborative efforts of two laboratories to optimize methods for processing, culturing, and analyzing mucosal lymphocytes. Rectal biopsy tissue was obtained by flexible sigmoidoscopy, which is rapid, minimally invasive, and well tolerated. Of the four methods compared for isolating mucosal mononuclear cells (MMC), collagenase digestion reproducibly yielded the most lymphocytes (4-7 x 10(6)). Furthermore, 0.5-1 x 10(6) MMC could be polyclonally expanded to yield 17 x 10(6) CD8+ T cells allowing mapping of responses to overlapping peptides spanning the HIV-1 genome using IFN-gamma enzyme-linked immunospot (ELISpot). Expansion also reduced the spontaneous IFN-gamma production normally detected in fresh MMC. Piperacillin-tazobactam and amphotericin B reduced contamination of MMC cultures to 4%. Taken together, these methods will be useful for studies of mucosal immunity to HIV-1 and other pathogens during natural infection and following vaccination.

[1]  I. M. Belyakov,et al.  The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. , 1998, The Journal of clinical investigation.

[2]  I. Chen,et al.  A Preponderance of CCR5+CXCR4+ Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 Infection , 2001, Journal of Virology.

[3]  M. Zeitz,et al.  Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. , 1995, Gut.

[4]  R. Koup,et al.  Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.

[5]  B. Shacklett.  Beyond 51Cr release: new methods for assessing HIV‐1‐specific CD8+ T cell responses in peripheral blood and mucosal tissues , 2002, Clinical and experimental immunology.

[6]  J. Berzofsky,et al.  Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. Belardelli,et al.  Human intestinal lamina propria lymphocytes are naturally permissive to HIV‐1 infection , 1999, European journal of immunology.

[8]  S. Rowland-Jones,et al.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. , 1999, Journal of immunology.

[9]  R. Colvin,et al.  Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: evidence for inter-T cell-mediated cytolysis. , 1991, Clinical immunology and immunopathology.

[10]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[11]  J. Mcghee,et al.  Progress towards a vaccine to prevent sexual transmission of HIV , 1996, Nature Medicine.

[12]  A. McMichael,et al.  Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. , 2002, AIDS research and human retroviruses.

[13]  E. Rosenberg,et al.  Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay , 2000, Journal of Virology.

[14]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[15]  D. Scadden,et al.  Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. , 2000, Blood.

[16]  D. Scadden,et al.  Prolonged survival and tissue trafficking following adoptive transfer of CD 4 z gene-modified autologous CD 4 1 and CD 8 1 T cells in human immunodeficiency virus – infected subjects , 2022 .

[17]  A. Justice,et al.  Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure. , 1998, Transplantation.

[18]  M. Zeitz,et al.  HIV‐1 p24 but not proviral load is increased in the intestinal mucosa compared with the peripheral blood in HIV‐infected patients , 1998, AIDS.

[19]  D. Nixon,et al.  Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. , 2001, Virology.

[20]  P. Doherty,et al.  The new numerology of immunity mediated by virus-specific CD8(+) T cells. , 1998, Current opinion in microbiology.

[21]  S. Rowland-Jones,et al.  Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Macken,et al.  Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects , 2003, AIDS.

[23]  M. Zeitz,et al.  Abnormalities in subset distribution, activation, and differentiation of T ceils isolated from large intestine biopsies in HIV infection , 1994 .

[24]  R. Steinman,et al.  A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. , 1999, AIDS.

[25]  D. Hoskin,et al.  CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[26]  K. Metzner,et al.  Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus. , 2000, Virology.

[27]  R. Johnson,et al.  Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. , 1997, Clinical immunology and immunopathology.

[28]  D. Kotler,et al.  Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. , 1991, The American journal of pathology.

[29]  R. Owen,et al.  AIDS and the gut , 1994, Journal of gastroenterology and hepatology.

[30]  J. Moore,et al.  The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. , 1999, The Journal of infectious diseases.

[31]  M. Zeitz,et al.  HIV/SIV Enteropathy , 1998, Annals of the New York Academy of Sciences.

[32]  R P Johnson,et al.  Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.

[33]  V. Maino,et al.  Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. , 1995, Blood.

[34]  E. Rosenberg,et al.  Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays , 2001, Journal of Virology.

[35]  D. Nixon,et al.  Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. , 2000, Virology.

[36]  V. Maino,et al.  Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. , 1998, Cytometry.

[37]  Yufei Wang,et al.  Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques , 1996, Nature Medicine.

[38]  C. Mackay,et al.  Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue , 2000, AIDS.

[39]  Todd M. Allen,et al.  Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques , 2001, Nature Network Boston.

[40]  S. Rowland-Jones,et al.  Cellular immune responses to HIV , 2001, Nature.

[41]  M. Zeitz,et al.  Mucosal HIV Infection , 1998, Pathobiology.

[42]  B. Walker,et al.  Immunologic control of HIV-1. , 2002, Annual review of medicine.

[43]  H. Lenz,et al.  Sensitive and reproducible quantitation of mucosal HIV-1 RNA and DNA viral burden in patients with detectable and undetectable plasma viral HIV-1 RNA using endoscopic biopsies. , 2001, Journal of virological methods.

[44]  L. Lanier,et al.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes , 1992, The Journal of experimental medicine.

[45]  J. Blanchard,et al.  Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. , 1999, Journal of immunology.

[46]  M. Zeitz,et al.  Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group. , 1994, Clinical and experimental immunology.

[47]  O Ouchterlony,et al.  Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. , 1988, Journal of immunological methods.

[48]  R. Colvin,et al.  Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. , 1987, Journal of immunology.

[49]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[50]  L. Bergmeier,et al.  Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. , 1996, Journal of immunology.

[51]  J. Giorgi,et al.  Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. , 2000, The Journal of infectious diseases.

[52]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[53]  K. Hertogs,et al.  Despite high concordance, distinct mutational and phenotypic drug resistance profiles in human immunodeficiency virus type 1 RNA are observed in gastrointestinal mucosal biopsy specimens and peripheral blood mononuclear cells compared with plasma. , 2001, The Journal of infectious diseases.

[54]  J. Klein,et al.  Most Murine CD8+ Intestinal Intraepithelial Lymphocytes Are Partially But Not Fully Activated T Cells1 , 2002, The Journal of Immunology.